leading the conversation. expanding the mission.
Fluorescene Group is a leading digital advocacy partner and a catalyst for progress within the eye care industry. As the parent organization behind some of optometry’s most engaged online communities, Fluorescene Group bridges the gap between eye care professionals and leading brands to drive innovation and foster meaningful collaboration.
At the heart of their mission is a commitment to lead the online discourse in eye care with scientific rigor and compassion. Their flagship platform, ODs on Technology, serves as a premier learning and news portal. It functions as the dedicated “tech-forward” sister site to the world-renowned ODs on Facebook group, expanding that community’s reach into deep-dive technical education.
Through the ODs on Technology ecosystem, members gain access to several distinct “innovation zones” tailored to the evolving needs of the profession:
- Deep Learning: Where experts go deep on the ideas reshaping eye care and health technology, emphasizing that human intelligence remains the driver behind AI.
- Mic Input: The home of Eye. Talk. Tech., an eye tech education podcast series that brings subject matter experts and real conversations to the intersection of eye care and technology.
- Early Access: Exclusive previews of tools and platforms—from quantum computing to AGI—tested before they move into the mainstream.
- Proof of Concept: A dedicated space where innovation is validated through clinical pilots, early adopters, and real-world results.
- Radar Feed: Real-time future signals and tech trends, from robotic-assisted surgery to the latest FDA frameworks on AI software.
- Plug & Play <pnp>: Action-oriented, straightforward resources focused on solving real-world clinical problems fast.
Fluorescene Group is powered by Dr. Alan Glazier, an optometric thought leader and an eye care industry expert who believes that technology is fundamentally transforming the profession. Their support of Optometry Giving Sight ensures that as the industry evolves, the global mission to eliminate preventable blindness remains at the forefront of digital innovation.
“At Fluorescene, we bring together real clinical insight, emerging technology, and authentic peer-to-peer conversation,” said CEO Nicole Skibinski. “Our commitment is to elevate the profession while ensuring that progress in technology continues to serve both the clinician and the global mission of improving vision care.”
We extend our sincere thanks to Fluorescene Group for their partnership and shared commitment to clinical excellence, practice growth, and our global mission to provide the gift of sight to those in need.
